news
Eczema drug effective against severe asthma
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
List view / Grid view
Asthma
news
LC-MS/MS used to identify novel prostaglandin-based compounds
Nitroproston is a novel prostaglandin-based compound with potential application in obstructive respiratory diseases...
news
Single steroid-bronchodilator treatment improves persistent asthma
UConn-led review finds new class of long-acting bronchodilators effective for patients with uncontrolled asthma...
news
Study of childhood asthma cautions against short-term high-dose treatment with steroids
Researchers in the US have found that a common practice among physicians to increase the use of steroids for worsening symptoms of asthma in children may be associated with slowing a child’s rate of growth.
news
Short-acting asthma relievers linked to infertility
New research indicates that women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women...
news
Steroid inhalers increase the risk of hard-to-treat infections
Older people who use steroid inhalers are more likely to suffer particular bacterial infections...
news
Non-invasive technique for probing cells may reveal disease
Engineers have devised a non-invasive way to assess a cell's mechanical properties simply by observation...
news
NICE recommends Cinqaero (reslizumab) for treatment of severe asthma
The National Institute for Health and Care Excellence (NICE) in England has recommended Teva Pharmaceutical Industries Ltd’s Cinqaero (reslizumab) in its Final Appraisal Determination (FAD).
news
Asia-Pacific asthma market will hit $6 billion by 2023
The Asia-Pacific (APAC) asthma therapeutics market is expected to grow significantly from $4.1 billion in 2016 to around $6 billion by 2023...
article
Improving the consistency of MDI drug delivery
A defining characteristic of inhaled drug delivery is variability in the dose received by the patient, as a result of physiology, for example, or the technique applied during use. This variability directly affects clinical outcomes so reducing it to a minimum is an important goal for the industry...
news
Orion seeks EU market authorisation for asthma/COPD product
22 December 2016 | By Niamh Louise Marriott, Digital Editor
Based on the results Orion is planning to apply for a marketing authorisation for the product in Europe. Orion currently estimates that the marketing...
article
Social media sourced Real World Evidence: A new wave in collecting data
3 October 2016 | By Peter Brady, CEO Orbital Media and Dr Martin Goldman, independent medical officer, Iatros Consulting
Dr Martin Goldman joins Peter Brady, Orbital Media's CEO, to discuss how to untap the potential of social media sourced real world evidence...
news
FDA approves Xolair to treat allergic asthma in children
11 July 2016 | By Victoria White, Digital Content Producer
The FDA has approved Genentech’s Xolair (omalizumab) to treat moderate to severe persistent asthma in children six to 11 years of age...
news
Tiotropium found to improve lung function of children with asthma
18 May 2016 | By Katie Sadler
New data has revealed tiotropium improves lung function in children who continue to experience asthma symptoms despite taking other maintenance therapies.
news
GSK’s Advair Diskus achieves primary endpoint in LABA safety study
17 March 2016 | By Victoria White
The VESTRI study compared Advair Diskus to fluticasone propionate monotherapy in children aged 4 – 11 years who have asthma...
